Sensorineural hearing loss in children with thalassemia major in Northern Greece

International Journal of Pediatric Otorhinolaryngology

Volumn 35, Issue 3, 1996, Pages 223-230

  Kontzoglou, G ^a,c   Koussi, A ^b   Tsatra, J ^b   Noussios, G ^a   Vital, V ^a   Sagarakis, G ^a   Athanassiou, M ^b  

^a Aristotle University of Thessaloniki   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c NONE   (Greece)

Author keywords

Children; Desferrioxamine; Hearing loss; Neurotoxicity; Thalassemia

Indexed keywords

DEFEROXAMINE;

ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NEUROTOXICITY; PERCEPTION DEAFNESS; PRIORITY JOURNAL;

EID: 0029896731     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5876(95)01308-3     Document Type: Article

References (13)

1. Biesalski, Phoniatrie and Radioaudiologie, Ein Überblick, G. Thieme Verlag, Stuttgart, 1973 (278-279).
2. Burian, K., Fanta, H. and Reisner, H. (1980) Neurootologie Diagnostic and Klinic, Ein Kompendium, G. Thieme Verlag, Stuttgart - New York 1980 (80-88).
3. Cohen, A., Martin, M., Mizanin, J., Konkle, D. and Schwartz, E. (1990) Vision and hearing during desferrioxamine therapy. J. Pediat., 117 (211) Aug. 326-330.
4. Freedman, M., Bentur, Y. and Koren, Y. (1989) Biological and Toxic Properties of Desferrioxamine, Xth Congress of the International Society of Haematology - Jerusalem, Israel 9:5, 579-600.
5. Hybels, R.L. (1979) Drug toxicity for the inner ear. Clinics North Am., 63, 309-319.
6. Olivieri, N.F., Buncic, J.R., Chew, E. et al. (1986) Visual and auditory neurotoxicity in patients receiving subcutaneous desferrioxamine infusions. N. Engl. J. Med., 314, 869-873.
7. Orton, R.B., Veber L.L. and Sulk, H.M.B. (1985) Ocular and auditory toxicity of long-term, high dose subcutaneous desferrioxamine therapy. Can. J. Ophalmol, 20, 153-156.
8. Porter, J.B., Jaswon, M.S., Huehns, E.R., East, C.A. and Hazell, J.W. (1988) Desferrioxamine ototoxicity: evaluation of risk factors in thalassemic patients and guidelines for safe dosage. Br. J. Haematol., 73, 403-409.
9. Porter, J.B. and Huehns, E.R. (1989) The toxic effects of desferrioxamine. Clinics in Haematology. Balliere'e Clinical Heamatology 2 (2), 459-474.
10. Stura, M., Arigliani, R., Molinari, A. and Tarantino, V. (1986) Evaluation of auditory function in homozygous β-thalassemia, Pediatr. Med. Clin. 8 (5), 703-705.
11. Vacalos, A., Athanassiou, M., Koussi, A., Fragakis, J., Tsatra, J., Terzi, V. and Preponis, H. (1989) Thalassemia and Hearing Loss, 4th Italian-Greek-Yugoslav Congress of Otorhinolaryngology, Head and Neck Surgery, Porto Caras, June 4-7.
12. Virgillis, D., Asgiolo, S., Sanna, F. et al. (1979) Auditory involvement in thalassemia major. Acta Haematologica, 51, 209-215.
13. Wonke, B., Hoffbrand, A., Aldouri, M., Wickens, D., Flynn, D., Stearns, M. and Warner P. (1989) Reversal of desferrioxamine induced auditory neurotoxicity during treatment with CaDTPA. Arch. Dis. Child., 64, 77-82.